While about 700,000 U.S. military personnel were deployed during the Gulf War conflict, casualties were relatively light compared with previous major conflicts. 4 Despite this relatively low casualty rate, the overall health status of these veterans is a significant public concern.
Some question whether there is sufficient oversight and collaboration directed at ensuring that the most appropriate and strategic priorities aimed to improve the health status of deployed soldiers and veterans are being addressed. Who is conducting what research where? Is this research resulting in America's sons and daughters getting the care they need and deserve?
This strategy research project defines Gulf War illnesses and highlights the evolution of the interagency committees which coordinated and conducted federal Gulf War illnesses research from its inception through FY05. It will explore congressionally directed funding trends, identifying in which agencies the funds are spent, and significant impacts and improvements resulting from research findings. Additionally, this project will address the impact of public opinion as it affects the national response. Regardless of partisan or political views, there is great interest in the federal response to health concerns of Gulf War and Global War on
Terrorism veterans as well as a significant interest to assist our service men and women who endure great sacrifice to protect our freedom.
Gulf War Illnesses Defined
Gulf War Syndrome or Gulf War Illnesses have been used to describe a collection of chronic signs and symptoms reported by U.S., British, Canadian, Czech, Danish, Saudi, Egyptian, Australian and other Coalition Armed Forces that were deployed to Operation Desert Storm in 1991. 5 Over 100,000 American veterans of Operations Desert Storm/Desert Shield, or approximately 15% of deployed U.S. Armed Forces, returned from the Persian Gulf and slowly (6-24 months or more) presented with a variety of complex signs and symptoms characterized by such symptoms as disabling fatigue, intermittent fevers, night sweats, headaches, confusion, irritability, and unexplained aches and pains, to name a few. 6 However, these veterans did not exhibit a single type of health problem or unique symptom complex (or syndrome) that could be labeled as such. Consequently, these veterans must be evaluated and treated as unique individuals. As such, assumptions cannot be made about the health of a Gulf War veteran who presents for clinical evaluation. Each veteran requires a medical history and screening examination, with treatment tailored to the specific needs of each and every patient. 7 The Institute of Medicine (IOM) recently released Gulf War and Health, Volume 4, a report that summarizes in one place the current status of health effects in veterans deployed to the Persian Gulf irrespective of exposure information. The charge of the IOM committee was to review, evaluate, and summarize pier-reviewed scientific and medical literature addressing the health status of Gulf War veterans. 8 Extensive searches of the scientific and medical literature were conducted and over 4000 potentially relevant references were retrieved. After assessment of the titles, abstracts and references found in the initial searches, the committee focused on 850 potentially relevant epidemiologic studies for its review and evaluation. 9 While examining these health outcomes in Gulf War-deployed veterans, it is quite evident that numerous researchers over the past decade have attempted to determine whether a set of symptoms reported by veterans could be defined as a unique syndrome or illnesses. These investigators have attempted, by using factor or cluster analysis, to define a unique health outcome; none however, has been identified. Although veterans who had deployed during the first Gulf War report more symptoms of illnesses than non-deployed veterans, no symptoms unique to Gulf War veterans have been found nor any increase in mortality or hospitalizations, though there may be increased incidence of a rare neurologic disease (amyotrophic lateral sclerosis or ALS Though the direct causes of these syndromes are typically elusive, it is clear that war sets in motion an undeniable cycle of physical, emotional, and fiscal consequences for war veterans and for society. 17 In light of the current war on terrorism with its increased operational tempo, longer and more frequent deployment cycles, and exposure to nontraditional, hostile combat conditions, it is critical that society become sensitive to and anticipate such war-related conditions to continue to manifest. Such modern conditions and influences, coupled with lessons learned as military history suggests, advocate the probability that we will see many more of these same post-combat disorders. Healthcare professionals must be ever vigilant in recognizing and appropriately treating these unexplained medical symptoms. 21 In response to veterans reporting health problems that they believed might be due to their participation in the war, and in concert with this new examination program, the VA, DoD, HHS, and other federal agencies initiated research studies and investigations into these health concerns and the consequences of possible hazardous exposures.
Evolution of the Interagency Committees
In 1993, President Clinton designated that the Secretary of the VA be responsible for coordinating research activities undertaken or funded by the executive branch of the federal government on the health consequences of service in the Gulf War. 22 As part of this coordination role, the VA is required to submit a yearly report to Congress on the results, status, and priorities of federal research activities related to health consequences of military service in the Gulf War. This report has been prepared by various interagency working groups over the years throughout the evolution of this initiative as coordination efforts shifted from strictly Gulf
War-related to focusing on all deployment-related health concerns. As the landscape of the war zones changed, so did the federal response and its resulting research activities.
Compelled by efforts to streamline interagency access to care for all Gulf War veterans, 
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Although no definitive cause was found to explain the health symptoms reported by Gulf
War veterans, RAND's research, along with the investigations of other researchers, identified a number of areas that could not be ruled out as possible causes of symptoms and, as such, required further research. Based on the published RAND work to date, these areas for further research included health effects from pyridostigmine bromide and pesticides. Moreover, because the battlefield is "dirty" in the sense that troops are exposed to many occupational hazards and to high levels of stress, RAND suggested additional investigations into the effect of factors in combination and of individuals' susceptibility to such exposures. These RAND studies also pointed to the critical need for better data collection and record keeping related to possible causes of Gulf War illnesses, an effort that DoD already has begun to significantly enhance and remedy.
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It was this lack of service member health and deployment data that hampered early investigations into the nature and causes of illnesses reported by many veterans and active duty service members following the Gulf War. 26 In response, Congress enacted legislation in November of 1997 requiring that DoD establish a system for assessing the medical condition of service members before and after their deployments to locations outside the United States.
This legislation also required the centralized retention of certain health-related data (namely, blood samples) associated with the service member's deployment and the establishment of a quality assurance program to ensure compliance.
27 DoD, however, was slow to respond. In September 2003, the Government Accountability Office, formerly known as the General Accounting Office, found that the services had not complied with DoD's force health protection and surveillance policies. Deficiencies were identified relating specifically to the policies requiring that active duty service members be assessed before and after deploying overseas, that the services document receipt of certain immunizations, and that health-related documentation be maintained in a centralized location. 28 One reason cited for these deficiencies and varied degrees of compliance was the lack of automated systems to record, capture, and retain this information. The process was such that pre and post-deployment health assessments were completed in hard copy and mailed to the Army Medical Surveillance Activity (AMSA), DoD's executive agent for collecting and retaining all the military services' deployment health-related documents, including the pre-deployment and post-deployment health assessments and immunizations. 29 DoD officials responded that automation of deployment health assessment forms and recording of service member immunizations would greatly improve the completeness of deployment data in the AMSA centralized database. DoD has addressed these shortcomings and has ongoing initiatives to accomplish these goals which will be discussed later in this writing. Committees on the results, status, and priorities of research activities related to the health consequences of military service in the Gulf War. 35 The VA has complied and has provided these reports to congressional committees since 1995. Additionally, the VA has carried out its coordinating role through the auspices of interagency committees, which have changed over time in response to federal research priorities and needs. 
Regardless of this complicated evolution of interagency committees that coordinated Gulf
War illnesses, the VA, DoD and HHS sponsored 300 distinct projects related to health problems affecting Gulf War veterans from FY92 through FY05. 38 A review indicates the scope of these federal research projects is very broad ranging from small pilot studies to large-scale epidemiology studies involving large populations and major center-based research programs.
As of September 30, 2005, 210 projects had been completed (70% of the 300 projects), and 90 projects (30%) were newly initiated or ongoing. 39 Additionally, federal funding for these research projects totaled $284.1 million during the period FY94 through FY05. 40 The following hard copy surveys as they prepared to deploy and again prior to departing the combat zone, which were then mailed to AMSA for analysis, electronic storage, and retention. Needless to say, this method of information capture was extremely inefficient and labor intensive resulting in deficient and unreliable data. Significant and renewed levels of commitment were invested and efforts to migrate from paper to electronic versions of these assessments were eventually accomplished by each of the services with DoD oversight and support.
In response to the GAO identified shortcomings, The Medical Protection System, or MEDPROS, was developed by the Army Medical Department to track all immunization, medical readiness, and deployability data for all active Army and reserve components. 44 The Air Force and Navy each have their own versions of a similar program and electronic tracking system.
Additionally, DoD is currently implementing a comprehensive electronic medical records system which is scheduled to be fully operational and deployed across the services in all locations by
2008. 45 The Armed Forces Health Longitudinal Technology Application (AHLTA), formerly known as the Composite Health Care System, includes pre-deployment and post-deployment health assessment forms and the capability to electronically record immunizations given to service members. 46 AHLTA is considered the DoD companion electronic health record to the VA's health information system and will greatly enhance the increasing exchange of digital health records for those veterans transitioning between DoD and the VA for their health care.
Further efforts are underway between DoD and VA as they continue to work cooperatively toward the development and implementation of a unified health data system that will ultimately include all health information of personnel through their military service and seamless transition into the VA healthcare system. at the three to six month post-deployment window. 48 As such, an interservice working group devised the Post Deployment Health Reassessment (PDHRA) program screening process to assist in identifying health concerns which may arise after service members redeploy from the combat zone. Recent field research indicates that health concerns, particularly those involving mental health, are more frequently identified several months following return from an operational deployment. 49 The PDHRA program facilitates early identification and treatment of emerging mental health and other deployment-related health concerns. Unlike the previous paper version of pre and post-deployment health assessments, the PDHRA survey was mandated from its inception to be performed electronically with the data to be sent directly to AMSA. Results from the PDHRA then become a permanent part of the individual's military health record and are included in the Defense Medical Surveillance System (DMSS). The DMSS serves as the central repository of medical surveillance data for the U.S. armed forces. The DMSS integrates data from sources worldwide in a continuously expanding relational database that documents the military and medical experiences of service members throughout their careers. 50 With the change in policy and process, thereby mandating electronic data collection of the PDHRA, data capture issues are far less problematic resulting in increased compliance and data quality.
The power and capabilities of the DMSS cannot be overstated in its contribution to revolutionizing the effective conduct of comprehensive medical and/or public health surveillance. Public health surveillance is the routine and systematic collection, analysis, interpretation, and reporting of population-based data for the purposes of detecting, characterizing, and countering threats to health, fitness, and performance of members of defined populations. 51 As a public health surveillance tool, DMSS is unprecedented, and has contributed greatly to data collection efforts in Gulf War illnesses research. Longitudinal health records are established and continuously updated for all individuals who have served in the armed forces since 1990. The DMSS documents the status of and changes in demographic and military characteristics as well as military and medical experiences of service members throughout their entire military careers. 52 What is impressive and most useful from the public health perspective is the fact that longitudinal comparisons can be made to follow the same service members over time, something that had been identified in previous GAO reports as lacking. Over time, the linkages of data relevant to individual characteristics, exposure states, medical events and specimens will provide powerful capabilities as medical events accrue among aging cohorts of service members. 53 Innovative support programs focusing on Gulf War illnesses and deployment-related issues, however, do not stop with the DoD. The VA recognized that the healthcare providers themselves, specifically nurse practitioners, physicians, and physician assistants require focused education and training to better prepare them to recognize, respond to, and treat this new and emerging patient population with unique needs. As part of the Veterans Health
Initiative, a continuing medical education independent self-study program was created and first have strong academic affiliations with medical and public health schools. 63 Charged with focusing on the most challenging medical issues, the mission of these centers is to provide service to combat veterans who have difficult to diagnose disabling illnesses through clinical care, risk communication, education and research addressing potential environmental exposures and adverse health outcomes. 64 Public Impact on Federal Support
The effect of public support of veterans has far ranging impact and influence, not the least of which is the impact upon the individual service member and the federal medical research Hughes' efforts would be to assimilate and integrate deployment-related health issues into national level information operations and public awareness campaigns. Efforts such as this would greatly standardize the messages received by the public and enable our legislators to set the conditions for unified, bipartisan action and appropriate health care funding and policy support. We owe our veterans continued vigilance and attention to their health issues. As stated by Senator Joseph Biden, "It's only when there is overwhelming public opinion that you're able to get overwhelming bipartisan congressional opinion." capabilities that will maintain traditional U.S. superiority against potential threats; and to continue the DoD's strong support for service members and their families. 68 Thus, given the public mandate and the resultant response from national leadership with regard to veterans' healthcare, it would seem that as the U.S. continues to pursue the war on terrorism in Iraq and Afghanistan, the federal medical research community will continue its obligation to monitor, evaluate and address the health of our war veterans to ensure they get the medical care they need and deserve.
This strategy research project defined Gulf War illnesses and highlighted the evolution of the interagency committees which coordinated and conducted federal Gulf War illnesses research from its inception through FY05. It explored congressionally directed funding trends, identified where the funds were spent, and discussed significant impacts and improvements resulting from research findings. Finally, this project addressed the impact of public opinion and suggests that public opinion coupled with appropriate national resolve and federal funding will continue to lead the national response addressing the health needs of all American veterans.
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